The unstoppable march of genomics into clinical practice continues. In an ideal world, the expanding use of genomic tools will identify disease before the onset of clinical symptoms and determine individualized drug treatment leading to precision medicine. However, many challenges remain for the successful translation of genomic knowledge and technologies into health advances and clinical practice.
Bio-IT World and Cambridge Healthtech Institute are again proud to host the Third Annual TCGC: The Clinical Genome Conference, inviting stakeholders from all arenas impacting clinical genomics to share new findings and solutions for advancing the application of clinical genome medicine.
TCGC brings together many constituencies for frank and vital discussion of the applications, questions and solutions surrounding clinical genome analysis, including scientists, physicians, diagnosticians, genetic counselors, bioinformaticists, ethicists, regulators, insurers, lawyers and administrators.
Topics addressing successful translation of genomic knowledge and technologies into advancement of clinical utility (medicines and diagnostics) include but are not limited to:
Scientific Investigation and Interpretation
- Technologies/Platforms
- WGS/Exome/Single-Cell Sequencing
- Variation
. Deletions and Amplifications
. Gene Expression
. Epigenetic Regulation
. Structural Changes
. Chromosomal Alterations
. Molecular Networks
- Drug and Diagnostic Targets
- Interpretation and Analysis Pipelines
- Case Studies
Clinical Integration and Implementation
- Mechanisms to Monitor Genomic Medicine
- Determining Clinical Utility
- Standardization/Regulation/Certification
- Reimbursement
- Data Management
- Diagnostic Lab Infrastructure
- HIT/Data Integration
- Reporting Results to Patients/Physicians
Call for Speakers
For a limited time, we are inviting researchers and clinicians applying genome analysis tools in clinical settings, as well as regulators and administrators implementing genomics into the clinic, to submit proposals for platform presentations. Please note that due to limited speaking slots, preference is given to abstracts from those within pharmaceutical and biopharmaceutical companies, regulators and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these genomic researchers are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
All proposals are subject to review by the organizers and Scientific Advisory Committee.
Please click here to submit a proposal.
Submission deadline for priority consideration: November 15, 2013
For more details on the conference, please contact:
Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
250 First Avenue, Suite 300
Needham, MA 02494
T: 781-972-5497
E: mabrown@healthtech.com
For exhibit and sponsorship opportunities, please contact:
Jay Mulhern
Manager, Business Development, Conferences & Media
Cambridge Healthtech Institute
250 First Avenue, Suite 300
Needham, MA 02494
T: 781-972-1359
E: jmulhern@healthtech.com